In another pediatric study, 11 out of 40 patients receiving a 41BB-based CAR had an allo-HCT following treatment, and two out of those 11 patients relapsed with CD19+ ALL [66]. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.